MedPath

Sennosides

Generic Name
Sennosides
Brand Names
Colace, EX-lax Chocolated, EX-lax Maximum Relief Formula, EX-lax Regular Strength Pills, Laxacin, Little Tummys Laxative Drops, Perdiem Overnight, Peri-colace Reformulated Feb 2008, Senexon, Senexon S, Senna Lax, Senna-time, Senokot, Senokot-S
Drug Type
Small Molecule
Chemical Formula
C42H38O20
CAS Number
517-43-1
Unique Ingredient Identifier
3FYP5M0IJX

Overview

Sennosides (also known as senna glycoside or senna) is a medication used to treat constipation and empty the large intestine before surgery. The medication is taken by mouth or via the rectum. It typically begins working in minutes when given by rectum and within twelve hours when given by mouth. It is a weaker laxative than bisacodyl or castor oil. Sennoside A, one of the sennosides present in the laxative medication, has recently proven effective in inhibiting the ribonuclease H (RNase H) activity of human immunodeficiency virus (HIV) reverse transcriptase .

Indication

For the over the counter treatment of constipation.

Associated Conditions

  • Autointoxication
  • Constipation
  • Haemorrhoids
  • Meteorism

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Geri-Care Pharmaceutical Corp
57896-458
ORAL
8.6 mg in 1 1
3/24/2025
Granulation Technology, Inc.
63561-0187
ORAL
8.6 mg in 1 1
7/30/2025
Bryant Ranch Prepack
71335-1181
ORAL
8.6 mg in 1 1
4/29/2025
Major Pharmaceuticals
0904-6725
ORAL
8.6 mg in 1 1
8/13/2025
PAI Holdings, LLC dba PAI Pharma
0121-4967
ORAL
8.8 mg in 5 mL
4/28/2025
Atlantis Consumer Healthcare, Inc.
67618-110
ORAL
8.6 mg in 1 1
4/17/2025
ATLANTIC BIOLOGICALS CORP.
17856-1127
ORAL
417.12 mg in 237 mL
5/23/2025
ATLANTIC BIOLOGICALS CORP.
17856-8237
ORAL
417.12 mg in 237 mL
7/31/2025
Bi-Mart
37835-214
ORAL
15 mg in 1 1
8/1/2025
Walgreens
0363-8750
ORAL
8.6 mg in 1 1
5/7/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
SENNA TABLET 7.5 mg
SIN02550P
TABLET
7.5 mg
4/19/1989
SENOKOT TABLET 7.5 mg
SIN04731P
TABLET
7.5 mg
6/25/1990

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
EASUWEI SENNOSIDES TABLETS 20MG
N/A
N/A
N/A
11/4/2024
SENCOLAX TAB 7.5MG
N/A
hysan pharmaceutical co ltd
N/A
N/A
7/9/2010
NEPURGO SENNOSIDES TABLETS 20MG
N/A
N/A
N/A
11/4/2024
EFORMAT SENNOSIDES TABLETS 20MG
N/A
N/A
N/A
11/4/2024
SURULAC-S ENTERIC-COATED TABLETS
N/A
N/A
N/A
1/21/2013

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
SANDOZ SENNA S
02247390
Tablet - Oral
8.6 MG
12/10/2004
GLYSENNID TAB 8.6MG
novartis consumer health canada inc.
00604402
Tablet - Oral
8.6 MG / TAB
1/1/1979
AGAROL WITH SENNOSIDES
numark laboratories, inc.
02240031
Liquid - Oral
25 MG / 15 ML
6/30/1999
SD'S TEA
health way products
00794309
Tea (Herbal) - Oral
10.5 MG / PCK
12/31/1994
NATURE'S REMEDY
glaxosmithkline consumer healthcare ulc
02239460
Tablet - Oral
8.6 MG
12/29/2000
DOCUSEN
02371650
Tablet - Oral
8.6 MG
N/A
SENNA S. TABLETS
sigma life sciences inc.
02246951
Tablet - Oral
8.6 MG
10/29/2003
LAXATIVE PLUS SOFTENER
cellchem pharmaceuticals inc.
02322420
Tablet - Oral
8.6 MG
N/A
CHOLASYN
rolmex international inc.
02236803
Tablet - Oral
12 MG
6/29/1998
JAMP-SENNA S
02291215
Tablet - Oral
8.6 MG
10/25/2010

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.